mTOR complexes in neurodevelopmental and neuropsychiatric disorders

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Neuroscience

• Publication date

  2013-10-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nn.3546PMID 24165680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treating Epilepsy in Tuberous Sclerosis with Everolimus: Getting Closer

  2014cited by this paper
• mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain

  2013cited by this paper
• Targeting the endocannabinoid system in the treatment of fragile X syndrome

  2013cited by this paper
• Disruption of Alcohol-Related Memories by mTORC1 Inhibition Prevents Relapse

  2013cited by this paper
• Rapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental Disorder

  2013cited by this paper
• Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.

  2013cited by this paper
• Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

  2013cited by this paper
• Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism

  2013cited by this paper
• mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons.

  2013cited by this paper
• Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation

  2013cited by this paper
• Everolimus treatment of refractory epilepsy in tuberous sclerosis complex

  2013cited by this paper
• Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex.

  2013cited by this paper
• Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology

  2013cited by this paper
• Selective Regulation of GluA Subunit Synthesis and AMPA Receptor-Mediated Synaptic Function and Plasticity by the Translation Repressor 4E-BP2 in Hippocampal Pyramidal Cells

  2013cited by this paper
• mTORC2 controls actin polymerization required for consolidation of long-term memory

  2013cited by this paper
• Exaggerated Translation Causes Synaptic and Behavioral Aberrations Associated with Autism

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• Autistic-like behavior and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice

  2012cited by this paper
• A unifying model for mTORC1-mediated regulation of mRNA translation

  2012cited by this paper
• Autism-related deficits via dysregulated eIF4E-dependent translational control

  2012cited by this paper
• The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.

  2012cited by this paper
• Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders

  2012cited by this paper
• Genomics, intellectual disability, and autism.

  2012cited by this paper
• Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities.

  2012cited by this paper
• Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia.

  2012cited by this paper
• Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen

  2012cited by this paper
• The functions and regulation of the PTEN tumour suppressor

  2012cited by this paper
• Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.

  2012cited by this paper
• Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

  2012cited by this paper
• PTEN signaling in autism spectrum disorders.

  2012cited by this paper
• The translational landscape of mTOR signalling steers cancer initiation and metastasis

  2012cited by this paper
• Endogenous viruses: insights into viral evolution and impact on host biology

  2012cited by this paper
• Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage

  2011cited by this paper
• Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function

  2011cited by this paper
• Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS‐Pten conditional knockout mice

  2011cited by this paper
• mTOR complex 2 signaling and functions

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• In brief

  2011cited by this paper
• FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

  2011cited by this paper
• Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.

  2011cited by this paper
• Mutations causing syndromic autism define an axis of synaptic pathophysiology

  2011cited by this paper
• Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.

  2011cited by this paper
• Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney.

  2011cited by this paper
• Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.

  2010cited by this paper
• Dysregulation of the Norepinephrine Transporter Sustains Cortical Hypodopaminergia and Schizophrenia-Like Behaviors in Neuronal Rictor Null Mice

  2010cited by this paper
• Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies

  2010cited by this paper
• Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly*

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission.

  2010cited by this paper
• Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice

  2009cited by this paper
• Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

  2009cited by this paper
• TOR complex 2: a signaling pathway of its own.

  2009cited by this paper
• DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212.

  2009cited by this paper
• Translational control of long-lasting synaptic plasticity and memory.

  2009cited by this paper
• DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

  2009cited by this paper
• An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1*

  2009cited by this paper
• Molecular mechanisms of mTOR-mediated translational control

  2009cited by this paper
• Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

  2009cited by this paper
• A Review on

  2008cited by this paper
• Deforolimus (AP23573) a novel mTOR inhibitor in clinical development

  2008cited by this paper
• Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

  2008cited by this paper
• Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity.

  2008cited by this paper
• Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex

  2008cited by this paper
• mGluR-Dependent Long-Term Depression Is Associated with Increased Phosphorylation of S6 and Synthesis of Elongation Factor 1A but Remains Expressed in S6K-Deficient Mice

  2008cited by this paper
• Reversing neurodevelopmental disorders in adults.

  2008cited by this paper
• Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis

  2008cited by this paper
• Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy

  2008cited by this paper
• Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function

  2008cited by this paper
• Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy

  2008cited by this paper
• Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

  2008cited by this paper
• SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs.

  2008cited by this paper
• Neurofibromin regulation of ERK signaling modulates GABA release and learning.

  2008cited by this paper
• The PTEN phosphatase is essential for long-term depression of hippocampal synapses

  2007cited by this paper
• Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1

  2007cited by this paper
• Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

  2007cited by this paper
• P-Rex1 Links Mammalian Target of Rapamycin Signaling to Rac Activation and Cell Migration*

  2007cited by this paper
• Cognitive deficits in Tsc1+/−mice in the absence of cerebral lesions and seizures

  2007cited by this paper
• Behavioral alterations in mice lacking the translation repressor 4E-BP2.

  2007cited by this paper
• Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

  2006cited by this paper
• Review and Future Directions

  2006cited by this paper
• Faculty Opinions recommendation of Pten regulates neuronal arborization and social interaction in mice.

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Pten regulates neuronal arborization and social interaction in mice.

  2006cited by this paper
• Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia

  2006cited by this paper
• The Translation Repressor 4E-BP2 Is Critical for eIF4F Complex Formation, Synaptic Plasticity, and Memory in the Hippocampus

  2005cited by this paper
• Neuroanatomic observations of the brain in autism: a review and future directions

  2005cited by this paper
• Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

  2004cited by this paper
• Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

  2004cited by this paper
• Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

  2004cited by this paper
• Clinical Pharmacokinetics of Everolimus

  2004cited by this paper
• Activation of the Phosphoinositide 3-Kinase-Akt-Mammalian Target of Rapamycin Signaling Pathway Is Required for Metabotropic Glutamate Receptor-Dependent Long-Term Depression

  2004cited by this paper
• Essential role of brain-derived neurotrophic factor in adult hippocampal function.

  2004cited by this paper
• TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase

  2004cited by this paper
• mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo

  2003cited by this paper
• Psychoneuroendocrinological links between chronic stress and depression.

  2003cited by this paper
• Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors.

  2003cited by this paper
• Astrocyte‐specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• The Molecular Biology of Memory Storage: A Dialogue Between Genes and Synapses

  2001cited by this paper
• A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus

  2001cited by this paper

• From genes to networks: neurobiological bases of neurodiversity across common developmental disorders.

  2026cites this paper
• An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice.

  2026cites this paper
• Phosphorylation-Dependent Regulation and Interactions of the Neutral Amino Acid Transporter SLC6A15: Implications for Major Depression and Neuropsychiatric Disorders

  2026cites this paper
• Postnatal reduction of eIF4E overexpression in D1-SPNs ameliorates KCNQ channel dysfunction, hyperexcitability and ASD-like behaviours

  2026cites this paper
• Nitric Oxide-Mediated S-Nitrosylation of TSC2 Drives mTOR dysregulation across Shank3 and Cntnap2 Models of Autism Spectrum Disorder.

  2026cites this paper
• Genetics of Autism Spectrum Disorder underscores the role of altered spontaneous neuronal activity as a catalyst for the neurodevelopmental anomalies.

  2026cites this paper
• Multi-behavioral fingerprints can identify potential modes of action for neuroactive environmental chemicals.

  2025cites this paper
• Immunomodulation of behavior impairment via spleen-specific targeting lipid nanoparticles in a MeCP2 transgenic mouse model

  2025cites this paper
• Paradoxical mTORC1-Dependent microRNA-mediated Translation Repression in the Nucleus Accumbens of Male Mice Consuming Alcohol Attenuates Glycolysis

  2025cites this paper
• Placental Omics and Neuropsychiatric Outcomes: A Systematic Review of Longitudinal Human Studies.

  2025cites this paper
• Obesogenic diet impairs memory consolidation via the hippocampal endocannabinoid system

  2025cites this paper
• Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders

  2025cites this paper
• Hippocampal Inhibitory Interneuron‐Specific DREADDs Treatment Alters mTORC1‐4E‐BP Signaling and Impairs Memory Formation

  2025cites this paper
• Neuroglial Dysregulation in Autism Spectrum Disorder: Pathogenetic Insights, Genetic Threads, and Therapeutic Horizons

  2025cites this paper
• ESC models of autism with copy-number variations reveal cell-type-specific translational vulnerability

  2025cites this paper
• Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome

  2025cites this paper
• The mammalian/mechanistic target of rapamycin complex 2 and its role in nervous system

  2025cites this paper
• Kefir enhances stress resilience and mitigates PTSD-related behavioral and hematological changes in mice

  2025cites this paper
• Transcriptional substrates of cortical thickness alterations in anhedonia of major depressive disorder.

  2025cites this paper
• 2-Ethylhexanol induces autism-like neurobehavior and neurodevelopmental disorders in zebrafish.

  2025cites this paper
• Rescue of hippocampal synaptic plasticity and memory performance by Fingolimod (FTY720) in APP/PS1 model of Alzheimer’s disease is accompanied by correction in metabolism of sphingolipids, polyamines, and phospholipid saturation composition

  2025cites this paper
• Discovery of indole- and quinolone-based inhibitors of the mTOR/Akt/Pi3K pathway for the potential treatment of autism and certain types of cancer.

  2025cites this paper
• iTRAQ proteomic analysis of the anterior insula in morphine‐induced conditioned place preference rats with high‐frequency deep brain stimulation intervention

  2025cites this paper
• Genotype–phenotype correlations with autism spectrum disorder-related traits in Noonan syndrome and Noonan syndrome with multiple lentigines: a cross-sectional study

  2025cites this paper
• Genetic Association and Functional Prediction of PTEN and TSC1 3′UTR Variants in Autism Spectrum Disorder Among Tunisian Patients

  2025influential citation
• Regualtion of LAMTOR1 by Oxidative Stress in Retinal Pigment Epithelium: Implications for Age-Related Macular Degeneration Pathogenesis.

  2024cites this paper
• Nano-alumina induced developmental and neurobehavioral toxicity in the early life stage of zebrafish, associated with mTOR.

  2024cites this paper
• Brain Specific RagA Overexpression Triggers Depressive‐Like Behaviors in Mice via Activating ADORA2A Signaling Pathway

  2024cites this paper
• A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders

  2024cites this paper
• Early Postnatal Exposure to Midazolam Causes Lasting Histological and Neurobehavioral Deficits via Activation of the mTOR Pathway

  2024cites this paper
• The NeuroProtect Formula: A Preventive Approach to AD Targeting the HIF-1/PI3K-AKT Signaling Pathway Evaluated through In Vivo, In Vitro, and Network Pharmacology Approaches.

  2024cites this paper
• ZFHX3 variants cause childhood partial epilepsy and infantile spasms with favourable outcomes

  2024cites this paper
• Complex activity and short-term plasticity of human cerebral organoids reciprocally connected with axons

  2024cites this paper
• Extended genome‐wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry

  2024cites this paper
• Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome

  2024cites this paper
• Spotlight on plasticity-related genes: Current insights in health and disease.

  2024cites this paper
• The early life exposome and autism risk: a role for the maternal microbiome?

  2024cites this paper
• Loss of interleukin 1 signaling causes impairment of microglia- mediated synapse elimination and autistic-like behaviour in mice.

  2024cites this paper
• Haploinsufficiency of ZFHX3, encoding a key player in neuronal development, causes syndromic intellectual disability.

  2024cites this paper
• Combinatorial transcriptional regulation establishes subtype-appropriate synaptic properties in auditory neurons

  2024cites this paper
• Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice.

  2024cites this paper
• Prenatal stress aggravates age-dependent cognitive decline, insulin signaling dysfunction, and the pro-inflammatory response in the APPNL-F/NL-F mouse model of Alzheimer's disease.

  2023cites this paper
• A novel neurodevelopmental syndrome caused by loss-of-function of the Zinc Finger Homeobox 3 (ZFHX3) gene

  2023cites this paper
• Immune synaptopathies: how maternal immune activation impacts synaptic function during development

  2023cites this paper
• Embryonic mercury exposure in zebrafish: Alteration of metabolites and gene expression, related to visual and behavioral impairments.

  2023cites this paper
• Dephosphorylation of 4EBP1/2 Induces Prenatal Neural Stem Cell Quiescence

  2023cites this paper
• A multi‐organ analysis of the role of mTOR in fetal alcohol spectrum disorders

  2023cites this paper
• Mast Cells in the Autonomic Nervous System and Potential Role in Disorders with Dysautonomia and Neuroinflammation.

  2023cites this paper
• Extended genome‐wide association study employing the African Genome Resources Panel identifies novel susceptibility loci for Alzheimer’s Disease in individuals of African ancestry

  2023cites this paper
• Maturation of nucleus accumbens synaptic transmission signals a critical period for the rescue of social deficits in a mouse model of autism spectrum disorder

  2023cites this paper
• Editorial: mTOR pathway malfunctions in neurodevelopmental disorders

  2023cites this paper
• miR-514a promotes neuronal development in human iPSC-derived neurons

  2023cites this paper
• Recency memory is altered in cocaine-withdrawn adolescent rats: Implication of cortical mTOR signaling.

  2023cites this paper
• mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.

  2023cites this paper
• Presynaptic Protein Synthesis in Brain Function and Disease

  2023cites this paper
• Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells

  2023cites this paper
• The role of opioid receptors in modulating Alzheimer’s Disease

  2023cites this paper
• Dendritic distribution of autophagosomes underlies pathway-selective induction of LTD

  2023cites this paper
• Stem cell models of Angelman syndrome

  2023cites this paper
• Opto4E-BP, an optogenetic tool for inducible, reversible, and cell type-specific inhibition of translation initiation

  2023cites this paper
• Effects of Early Exposure to Isoflurane on Susceptibility to Chronic Pain Are Mediated by Increased Neural Activity Due to Actions of the Mammalian Target of the Rapamycin Pathway

  2023cites this paper
• PLPPR4 haploinsufficiency causes neurodevelopmental disorders by disrupting synaptic plasticity via mTOR signalling

  2023cites this paper
• Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss

  2023cites this paper
• Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)

  2023cites this paper
• Molecular mechanisms of exercise intervention in alleviating the symptoms of autism spectrum disorder: Targeting the structural alterations of synapse

  2023cites this paper
• Autism spectrum disorder and brain volume link through a set of mTOR-related genes.

  2023cites this paper
• RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma

  2022cites this paper
• TRIM32 Deficiency Impairs the Generation of Pyramidal Neurons in Developing Cerebral Cortex

  2022cites this paper
• Disentangling the molecular mechanisms underlying the retrieval and extinction of morphine withdrawal-associated memories in the basolateral amygdala and dentate gyrus

  2022influential citation
• A review on computational tools for analytical visualisation and molecular interactions of sncRNAs: prospects in NDDs

  2022cites this paper
• Functional Genomic Analysis of Amphetamine Sensitivity in Drosophila

  2022cites this paper
• Non-canonical functions of a mutant TSC2 protein in mitotic division

  2022cites this paper
• Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics

  2022cites this paper
• Long-lasting BDNF signaling alterations in the amygdala of adolescent female rats exposed to the activity-based anorexia model

  2022cites this paper
• microRNA Biology on Brain Development and Neuroimaging Approach

  2022cites this paper
• miR-34b-3p Inhibition of eIF4E Causes Post-stroke Depression in Adult Mice

  2022cites this paper
• Molecular Features Triggered by Antipsychotic Medication in Brain Cells.

  2022cites this paper
• mTORC1 function in hippocampal parvalbumin interneurons: regulation of firing and long-term potentiation of intrinsic excitability but not long-term contextual fear memory and context discrimination

  2022cites this paper
• GSK3β and mTORC1 Represent 2 Distinct Signaling Markers in Peripheral Blood Mononuclear Cells of Drug-Naive, First Episode of Psychosis Patients

  2022cites this paper
• Biallelic loss-of-function variants in RABGAP1 cause a novel neurodevelopmental syndrome.

  2022cites this paper
• The Phosphofurin Acidic Cluster Sorting Protein 2 (PACS-2) E209K Mutation Responsible for PACS-2 Syndrome Increases Susceptibility to Apoptosis

  2022cites this paper
• Acute rapamycin rescues the hyperexcitable phenotype of accumbal medium spiny neurons in the valproic acid rat model of autism spectrum disorder.

  2022cites this paper
• Neuronal mTOR Outposts: Implications for Translation, Signaling, and Plasticity

  2022influential citation
• Differential expression of gene co-expression networks related to the mTOR signaling pathway in bipolar disorder

  2022cites this paper
• Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1.

  2022cites this paper
• mTORC2 Inhibition Improves Morphological Effects of PTEN Loss, But Does Not Correct Synaptic Dysfunction or Prevent Seizures

  2022cites this paper
• Molecular Mechanisms Underlying the Retrieval and Extinction of Morphine Withdrawal-Associated Memories in the Basolateral Amygdala and Dentate Gyrus

  2022influential citation
• Binding site hotspot map of PI3Kα and mTOR in the presence of selective and dual ATP-competitive inhibitors

  2021cites this paper
• Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2

  2021cites this paper
• PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats

  2021cites this paper
• Regulation of mRNA translation in stem cells; links to brain disorders.

  2021cites this paper
• Induced pluripotent stem cells for modeling Angelman syndrome

  2021cites this paper
• Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly

  2021cites this paper
• Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice

  2021cites this paper
• Multiplexed Neurotransmission Emulated by a p–n Cross Nanowire Synaptic Transistor for Satiety, Depression, and Drug Withdrawal

  2021cites this paper
• CGRP overexpression does not alter depression-like behavior in mice

  2021cites this paper
• Prenatal treatment with rapamycin restores enhanced hippocampal mGluR-LTD and mushroom spine size in a Down’s syndrome mouse model

  2021cites this paper
• Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice

  2021cites this paper
• Gene Dosage- and Age-Dependent Differential Transcriptomic Changes in the Prefrontal Cortex of Shank2-Mutant Mice

  2021cites this paper
• Sensitive period for rescuing parvalbumin interneurons connectivity and social behavior deficits caused by TSC1 loss

  2021cites this paper